Social
Social
Explore our new website and discover how we harness the power of evolution with our proprietary, first-of-its-kind ResCu platform to search and develop novel therapies to defeat treatment-resistant cancers! #evolution #precisionmedicine #cancer
https://resistance.bio/
Join our webinar on September 8 where Dr. Nick Goldner of @resistanceBio will discuss the cancer resistome and the interconnected genomic and non-genomic processes that results in cancer not responding to treatment. Learn more and register: http://ms.spr.ly/6019XG6pc #LifeSciences
90% of cancer deaths can be attributed to treatment-resistant tumors. resistanceBio is hiring a research associate to help us discover new cancer therapies that can treat those who run out of treatment options.
#HiringPhenomenalTalent #CancerResearch
https://www.linkedin.com/jobs/view/2606169456/
Congratulations @janiszewska_lab!
Our latest work is out! Rare stroma populations involved in resistance to different HER2 targeting agents in breast cancer PDX models + heterogeneity analysis (STAR-FISH & CycIF) of human BC from HER2-targeting clinical cohorts #SingleCell @JCI_insight https://insight.jci.org/articles/view/147617
We are proud to be working with @SethDeGroot; we developed the ResCu (Resistance Culturing) system with his support. ResCu has enabled us to identify novel drugable targets in treatment-resistant cancer that allow us to target unexplored cancer susceptibilities.
The Resistance Bio Thesis
Tldr - stated without hyperbole, @resistanceBio is one of humanity’s best shots at a developing a cure for cancer, and I couldn’t be more proud to support them.
https://sethdegroot.substack.com/p/the-resistance-bio-thesis?r=5ajnp&utm_campaign=post&utm_medium=web&utm_source=twitter
resistanceBio is proud to be partnering with 50 Years!
@radgenomics @Sethbannon @CancerConnector @akiykau @bulowcr @DrNickGoldner
@resistanceBio by @fiftyyears
resistanceBio
Fifty Years partners with resistanceBio to combat treatment resistant cancer
fiftyyears.substack.com
We’re excited to come out of stealth with this great piece in @FierceBiotech @amirahalidrus
Could a single pill treat a tumor today and head off its drug resistance mechanisms tomorrow? ResistanceBio is on the case
Cancer drugs stop working when malignant cells develop molecular changes that allow them to evade the drugs’ e...
www.fiercebiotech.com
Global Biobank Market is estimated to be US$ 113.23 billion by 2030 with a CAGR of 6.1% during the forecast period
Top Key Players: @biolifesol , @PHCbiomed , @thermofisher , @resistanceBio , @weare54gene ,
To Know more: https://bit.ly/3HDkNCC
Founder Spotlight🔬: Nicholas Goldner @ resistanceBio
Learn more about @DrNickGoldner & @resistanceBio below...
Founder Spotlight #19: Nicholas Goldner @ resistanceBio
BIOS — The Nucleus of Life Science Startup Innovation 🚀
ow.ly
Founder Spotlight🔬: Nicholas Goldner @ resistanceBio
Learn more about @DrNickGoldner & @resistanceBio below...
Founder Spotlight #19: Nicholas Goldner @ resistanceBio
BIOS — The Nucleus of Life Science Startup Innovation 🚀
ow.ly
On November 18, leading scientists will discuss how revealing #cancer vulnerabilities can help combat resistance in our panel discussion. Learn more and register:
https://bit.ly/3bUCZd7
#LifeSciences
@Sunnybrook @DrNickGoldner @resistanceBio
On November 18, leading scientists will discuss how revealing #cancer vulnerabilities can help combat resistance in our panel discussion.
Learn more and register:
https://event.on24.com/wcc/r/3492215/1471E5C5077D63F51EF7D4AFDE1C5151?partnerref=CancerTW
#LifeSciences @Sunnybrook @DrNickGoldner @resistanceBio
Join leading scientists, Dr. David Andrews of @Sunnybrook Research Institute, Dr. Stephen B. Baylin and @DrNickGoldner of @resistanceBio on November 18 as they discuss cancer evolution and new therapeutic approaches to tackle resistance. Register here: http://ms.spr.ly/6017kHDYP
#GPCRTherapeuticsUSA
#ImYoo
@JunoDiagnostics
#Methid
@MimosaTher
#NeurophthTherapeutics
#NucleoLifeSciences
#Panazee
#Phinomics
#PraxisBioresearch
@PrinterPrezz
@resistanceBio
#Seqmatic
#SeranovaBio
#SinglePass
#SolenaAg
#STATegics
#TevaPharmaceuticalIndustries
Join our webinar on September 8 where Dr. Nick Goldner of @resistanceBio will discuss the cancer resistome and the interconnected genomic and non-genomic processes that results in cancer not responding to treatment. Learn more and register: http://ms.spr.ly/6019XG6pc #LifeSciences
Founder Spotlight: Nicholas Goldner @resistanceBio , which enables the development of novel treatments for patients with treatment-resistant cancer🔬
Founder Spotlight #19: Nicholas Goldner @ resistanceBio
BIOS — The Nucleus of Life Science Startup Innovation 🚀
medium.com
The Resistance Bio Thesis
Tldr - stated without hyperbole, @resistanceBio is one of humanity’s best shots at a developing a cure for cancer, and I couldn’t be more proud to support them.
The Resistance Bio Thesis
Drug resistance continues to be the principal limiting factor to achieving cures in patients with cancer. The proble...
sethdegroot.substack.com
resistanceBio is proud to be partnering with 50 Years!
@radgenomics @Sethbannon @CancerConnector @akiykau @bulowcr @DrNickGoldner
@resistanceBio by @fiftyyears
resistanceBio
Fifty Years partners with resistanceBio to combat treatment resistant cancer
fiftyyears.substack.com
Building @resistanceBio has been one of the hardest and most rewarding opportunities! We get to make the change we need to see in the world, because of incredible partners like @sethbannon and @elamadej!
@resistanceBio by @fiftyyears
resistanceBio
Fifty Years partners with resistanceBio to combat treatment resistant cancer
fiftyyears.substack.com
Great coverage of @resistanceBio’s exciting work to develop cancer therapeutics that target tumor drug-resistance!
http://www.resistance.bio
Could a single pill treat a tumor today and head off its drug resistance mechanisms tomorrow? ResistanceBio is on the case
Cancer drugs stop working when malignant cells develop molecular changes that allow them to evade the drugs’ e...
www.fiercebiotech.com
What if I told you cancer cells readily adapt to and resist treatment, including SoC monoclonal antibodies?
What if I told you there’s a way to flip cancer's adaptability from a superpower to an Achilles’ heel?
Excited to finally be able to talk about @resistanceBio!
We’re excited to come out of stealth with this great piece in @FierceBiotech https://www.fiercebiotech.com/biotech/could-a-single-pill-treat-a-tumor-today-and-head-off-its-drug-resistance-mechanisms @amirahalidrus
